Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Addition of a general surgeon without addition of appropriate support is inadequate to improve outcomes of trauma patients in a rural setting: a cohort study of 1962 consecutive patients.
Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone.
Alterations of the human gut microbiome in multiple sclerosis.
Erratum to: 'Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia'.
Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Postural tremor and chronic inflammatory demyelinating polyneuropathy.
Gait Disturbance as the Presenting Symptom in Young Children With Anti-NMDA Receptor Encephalitis.
Cholinergic system and neuroinflammation: Implication in multiple sclerosis.
Corrigendum.
Correlation between antibodies to bisphenol A, its target enzyme protein disulfide isomerase and antibodies to neuron-specific antigens.
Social isolation impairs remyelination in mice through modulation of IL-6.
Differential effects of social isolation in adolescent and adult mice on behavior and cortical gene expression.
A decade of natalizumab and PML: Has there been a tacit transfer of risk acceptance?
Targeting "bad" B cells in multiple sclerosis: Could laquinimod be part of the armamentarium?
[Appraisal of the formation of afterimages by means of a new computer application in patients with demyelinating optic neuropathies].
Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus.
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
Fitness and its association with fatigue in persons with multiple sclerosis.
Rituximab for treating multiple sclerosis: Off-label but on target.
The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica.
Challenges in pediatric chronic inflammatory demyelinating polyneuropathy.
IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.
Pros and cons of medical cannabis use by people with chronic brain disorders.
Ontogeny of Tissue-Resident Macrophages.
Pages
« first
‹ previous
…
827
828
829
830
831
832
833
834
835
…
next ›
last »